Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ATE Antibe Therapeutics Inc

0.00 (0.00%)
Feb 22 2024 - Closed
Delayed by 15 minutes

Antibe Therapeutics Financial Summary

The current ATE market cap is 21.32M. The company's latest EPS is CAD -0.3700 and P/E is -2.65.

Year End March 30 2023 20192020202120222023
CAD ($)CAD ($)CAD ($)CAD ($)CAD ($)
Total Revenue 9.54M9.99M10.95M13.6M6.99M
Operating Income -12.19M-16.24M-24.47M-22.02M-14.96M
Net Income -12.82M-19.34M-26.3M-25.06M-19.48M
Year End March 30 2023 20192020202120222023
CAD ($)CAD ($)CAD ($)CAD ($)CAD ($)
Total Assets 14.82M13.84M81.74M89.16M70.56M
Total Liabilities 7.38M10.06M31.48M32.33M30.4M
Total Equity 7.44M3.78M50.26M56.83M40.17M

Cash Flow

Year End March 30 2023 20192020202120222023
CAD ($)CAD ($)CAD ($)CAD ($)CAD ($)
Operating -7.06M-11.94M-105k-16.92M-16.31M
Investing -257k98k-264k-20.22M-11.83M
Financing 9.59M12M66.16M-26k80k
Market Cap 21.32M
Price to Earnings Ratio -2.65
Price to Sales Ratio 7.39
Price to Cash Ratio 7.64
Price to Book Ratio 1.28
Dividend Yield -

Share Statistics

Shares Outstanding 52.64M
Average Volume (1 week) 0
Average Volume (1 Month) 0
52 Week Change -
52 Week High -
52 Week Low -
Spread (Intraday) 0.01 (1.22%)

Company Info

Company Name Antibe Therapeutics Inc
Address 15 prince arthur avenue
toronto, ontario M5R 1B2
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock